NK/γδ T cell-enriched cell therapy
/ Case Comprehensive Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
December 05, 2024
Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: Leland Metheny | N=10 ➔ 0 | Not yet recruiting ➔ Withdrawn
Enrollment change • Trial withdrawal • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Bone Marrow Transplantation • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Myeloproliferative Neoplasm • Neutropenia • Oncology • Transplantation
March 02, 2024
Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: Leland Metheny | Trial completion date: Jun 2025 ➔ Jun 2026 | Trial primary completion date: Jun 2024 ➔ Jun 2025
Trial completion date • Trial primary completion date • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Bone Marrow Transplantation • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Myeloproliferative Neoplasm • Neutropenia • Oncology • Transplantation
November 21, 2023
Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: Leland Metheny | Trial completion date: Sep 2024 ➔ Jun 2025 | Trial primary completion date: Nov 2023 ➔ Jun 2024
Trial completion date • Trial primary completion date • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Bone Marrow Transplantation • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Myeloproliferative Neoplasm • Neutropenia • Oncology • Transplantation
May 25, 2023
Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: Leland Metheny | Trial completion date: Sep 2023 ➔ Sep 2024 | Trial primary completion date: Nov 2022 ➔ Nov 2023
Trial completion date • Trial primary completion date • Acute Myelogenous Leukemia • Bone Marrow Transplantation • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Myeloproliferative Neoplasm • Oncology • Transplantation
1 to 4
Of
4
Go to page
1